Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022282004> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2022282004 endingPage "269" @default.
- W2022282004 startingPage "266" @default.
- W2022282004 abstract "Comparer les pourcentages de résistance aux antibiotiques de Salmonella enterica responsable d'infections humaines à Lomé sur deux périodes. Trois cent trente-deux souches de Salmonella enterica isolées entre 1998–2002 (n = 168) et 2003–2004 (n = 164) ont été inclues dans l'étude. L'antibiogramme a été réalisé par la méthode de diffusion sur gélose Mueller-Hinton. La répartition des 332 souches a été, 147 (44,3 %) Salmonella Typhi, 97 (29,2 %) Salmonella Typhimurium, 74 (22,3 %) Salmonella Enteritidis et 14 (4,2 %) Salmonella spp. Les proportions de souches résistantes au chloramphénicol, à l'amoxicilline et au cotrimoxazole (antibiotiques de première intention) sont passées respectivement de 33, 46 et 57 % en 1998–2002 à 73, 79 et 82 % en 2003–2004 (p < 0,0001). Sur les 164 souches de salmonelles isolées entre 2003–2004, 108 (72 %) étaient résistantes à la fois au chloramphénicol, cotrimoxazole et amoxicilline. Le pourcentage de souches résistantes à la ciprofloxacine, aux aminosides ou à la ceftriaxone était inférieur à 10 %. Les fluoroquinolones et les céphalosporines de troisième génération constituent actuellement les antibiotiques de première intention dans le traitement des salmonelloses. This study had for aim to compare antibiotic resistance of 332 Salmonella enterica strains identified in human samples in the course of infections, in Lome. The strains were collected over two periods: 1998–2002 (N = 168) and 2003–2004 (N = 164). The antibiotic susceptibility test was performed by disk diffusion assay. The main serotypes identified were 147 Salmonella Typhi (44.3%), 97 Salmonella Typhimurium (29.2%), and 74 Salmonella Enteritidis (22.3%). The proportions of strains resistant to chloramphenicol, cotrimoxazol, and amoxicillin (first line antibiotics) varied respectively from 33, 46, and 57% in 1998–2002 to 73, 79, and 82% in 2003–2004 (P < 0.0001). The percentage of resistance to ciprofloxacin or ceftriaxone was inferior to 10%. Fluoroquinolones and third generation cephalosporins have become the first line antibiotics for the treatment of Salmonella in Lome (Togo)." @default.
- W2022282004 created "2016-06-24" @default.
- W2022282004 creator A5000776312 @default.
- W2022282004 creator A5026231769 @default.
- W2022282004 creator A5030390826 @default.
- W2022282004 creator A5068353058 @default.
- W2022282004 creator A5073857536 @default.
- W2022282004 date "2007-05-01" @default.
- W2022282004 modified "2023-09-30" @default.
- W2022282004 title "Émergence des souches de salmonelles multirésistantes aux antibiotiques à Lomé (Togo)" @default.
- W2022282004 cites W1979259851 @default.
- W2022282004 cites W1990112342 @default.
- W2022282004 cites W2000959591 @default.
- W2022282004 cites W2003948461 @default.
- W2022282004 cites W2004886366 @default.
- W2022282004 cites W2022028189 @default.
- W2022282004 cites W2073207863 @default.
- W2022282004 cites W2073421290 @default.
- W2022282004 cites W2080528409 @default.
- W2022282004 cites W2095655760 @default.
- W2022282004 cites W2116751640 @default.
- W2022282004 cites W2131708510 @default.
- W2022282004 cites W2132515225 @default.
- W2022282004 cites W2144233138 @default.
- W2022282004 cites W2171531891 @default.
- W2022282004 cites W2417038292 @default.
- W2022282004 doi "https://doi.org/10.1016/j.medmal.2007.02.002" @default.
- W2022282004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17459634" @default.
- W2022282004 hasPublicationYear "2007" @default.
- W2022282004 type Work @default.
- W2022282004 sameAs 2022282004 @default.
- W2022282004 citedByCount "8" @default.
- W2022282004 countsByYear W20222820042014 @default.
- W2022282004 countsByYear W20222820042015 @default.
- W2022282004 countsByYear W20222820042016 @default.
- W2022282004 countsByYear W20222820042023 @default.
- W2022282004 crossrefType "journal-article" @default.
- W2022282004 hasAuthorship W2022282004A5000776312 @default.
- W2022282004 hasAuthorship W2022282004A5026231769 @default.
- W2022282004 hasAuthorship W2022282004A5030390826 @default.
- W2022282004 hasAuthorship W2022282004A5068353058 @default.
- W2022282004 hasAuthorship W2022282004A5073857536 @default.
- W2022282004 hasConcept C2781065037 @default.
- W2022282004 hasConcept C3019249092 @default.
- W2022282004 hasConcept C501593827 @default.
- W2022282004 hasConcept C523546767 @default.
- W2022282004 hasConcept C54355233 @default.
- W2022282004 hasConcept C86803240 @default.
- W2022282004 hasConcept C89423630 @default.
- W2022282004 hasConceptScore W2022282004C2781065037 @default.
- W2022282004 hasConceptScore W2022282004C3019249092 @default.
- W2022282004 hasConceptScore W2022282004C501593827 @default.
- W2022282004 hasConceptScore W2022282004C523546767 @default.
- W2022282004 hasConceptScore W2022282004C54355233 @default.
- W2022282004 hasConceptScore W2022282004C86803240 @default.
- W2022282004 hasConceptScore W2022282004C89423630 @default.
- W2022282004 hasIssue "5" @default.
- W2022282004 hasLocation W20222820041 @default.
- W2022282004 hasLocation W20222820042 @default.
- W2022282004 hasOpenAccess W2022282004 @default.
- W2022282004 hasPrimaryLocation W20222820041 @default.
- W2022282004 hasRelatedWork W1972298183 @default.
- W2022282004 hasRelatedWork W2020855419 @default.
- W2022282004 hasRelatedWork W2026176496 @default.
- W2022282004 hasRelatedWork W2050333345 @default.
- W2022282004 hasRelatedWork W2130181934 @default.
- W2022282004 hasRelatedWork W2149586621 @default.
- W2022282004 hasRelatedWork W2202055418 @default.
- W2022282004 hasRelatedWork W2335684962 @default.
- W2022282004 hasRelatedWork W4252053432 @default.
- W2022282004 hasRelatedWork W4312871856 @default.
- W2022282004 hasVolume "37" @default.
- W2022282004 isParatext "false" @default.
- W2022282004 isRetracted "false" @default.
- W2022282004 magId "2022282004" @default.
- W2022282004 workType "article" @default.